The cannabinoid CB1 receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus

被引：58
|
作者：
Tzavara, ET [1 ]
Perry, KW [1 ]
Rodriguez, DE [1 ]
Bymaster, FP [1 ]
Nomikos, GG [1 ]
机构：
[1] Eli Lilly & Co, Lilly Corp Ctr, Neurosci Discovery Res, Indianapolis, IN 46285 USA
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 2001年 / 426卷 / 03期
关键词：
microdialysis; norepinephrine; SR141716A;
D O I：
10.1016/S0014-2999(01)01228-6
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The effects of the selective cannabinoid CB1 receptor antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide-hydrochloride (SR141716A) on extracellular concentrations of norepinephrine and 5-hydroxytryptamine (5-HT) were assessed by in vivo microdialysis in the anterior hypothalamus of freely moving rats. SR14716A (0.3, 1, 3 mg/kg, i.p.) dose-dependently increased norepinephrine efflux to about 300% of baseline, without affecting 5-HT levels. This increase in norepinephrine outflow could play an important role in the pharmacological and potentially therapeutic actions of SR141716A. (C) 2001 Published by Elsevier Science B.V.
引用
收藏
页码：R3 / R4
页数：2
相关论文
共 50 条
  • [1] Characterisation of the rat cerebella CB1 receptor using SR141716A, a central cannabinoid receptor antagonist
    Hirst, RA
    Almond, SL
    Lambert, DG
    NEUROSCIENCE LETTERS, 1996, 220 (02) : 101 - 104
  • [2] Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats
    Mansbach, RS
    Rovetti, CC
    Winston, EN
    Lowe, JA
    PSYCHOPHARMACOLOGY, 1996, 124 (04) : 315 - 322
  • [3] Inverse agonist effects of the cannabinoid CB1 receptor antagonist SR141716A in rat brain.
    Sim-Selley, LJ
    Brunk, LK
    Selley, DE
    FASEB JOURNAL, 2000, 14 (08): : A1447 - A1447
  • [4] The cannabinoid (CB1) receptor antagonist SR141716A blocks capacitative calcium influx in astrocytes
    Rzigalinski, BA
    Sitterding, HA
    Ellis, EF
    FASEB JOURNAL, 2001, 15 (05): : A926 - A926
  • [5] The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food
    Thornton-Jones, ZD
    Vickers, SP
    Clifton, PG
    PSYCHOPHARMACOLOGY, 2005, 179 (02) : 452 - 460
  • [6] The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food
    Zoë D. Thornton-Jones
    Steven P. Vickers
    Peter G. Clifton
    Psychopharmacology, 2005, 179 : 452 - 460
  • [7] SR141716A is an inverse agonist at the human cannabinoid CB1 receptor
    Landsman, RS
    Burkey, TH
    Consroe, P
    Roeske, WR
    Yamamura, HI
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 334 (01) : R1 - R2
  • [8] The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the rat
    Chapman, V
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (08) : 1765 - 1767
  • [9] Effects of the cannabinoid CB1 receptor antagonist, SR141716A, after Δ9-tetrahydrocannabinol withdrawal
    Beardsley, PM
    Martin, BR
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 387 (01) : 47 - 53
  • [10] SR141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine
    Masserano, JM
    Karoum, F
    Wyatt, RJ
    BEHAVIOURAL PHARMACOLOGY, 1999, 10 (04): : 429 - 432
12345